Eurofins Genomics is an internationally leading provider of genomic services and products.
Creating synthetic DNA involves sequentially adding nucleotide bases, which are the “letters” of life, to generate a specific sequence called oligonucleotide synthesis and genes.
Sequencing is the process of decoding the “letters” of life to assemble a genomic sequence. We serve all sequencing needs under one company, including Nanopore whole plasmid sequencing, Sanger sequencing, and NGS sequencing.
Double-stranded, sequence-verified genes or gene fragments to clone into a vector of your choice.
With facilities in Europe, North America, and Asia, we support clients in the pharma, diagnostics, food, agriculture, biotechnological and research markets with services in DNA synthesis, DNA sequencing, gene synthesis, genotyping, and bioinformatics.